跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FASENRA PEN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
FASENRA PEN
Authorized
STANDARD
FASENRA PEN
astrazeneca canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
d45d3f987b183154
Company
astrazeneca canada inc
Type
Standard
Approval Details
Approval Id
d45d3f987b183154
Drug Approval Canada Name
FASENRA PEN
Product Name
FASENRA PEN
Status
Marketed
Status Date
2021-01-13
Original Market Date
2021-01-13
Din
02496135
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous
Schedule
Schedule D , Prescription
Ahfs
48:10.20
Atc Original
R03DX10 BENRALIZUMAB
Atc Name
r 03 dx 10
Aig Number
0159970001
Company Name
astrazeneca canada inc
Company Address
1004 Middlegate Road, Suite 5000, Mississauga, Ontario, Canada, L4Y 1M4
Active Ingredients
BENRALIZUMAB
30 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
d45d3f987b183154
Type
Standard
Back to Health Canada Approvals